Anti-Apo B-100 Autoantibody is a Marker of Unstable Coronary Plaque

Aims: Cardiovascular diseases (CVD) are a global leading cause of mortality. However, few biomarkers are available to predict future coronary plaque rupture. We have recently demonstrated that low levels of anti-apolipoprotein B-100 autoantibody (anti-apo B-100 Ab) correlated with an increased CVD r...

Descripción completa

Detalles Bibliográficos
Autores principales: Imai, Minami, Kawamura, Mari, Kochi, Ikoi, Matsuoka, Tetsuro, Kihara, Shinji, Yamamoto, Hiroyasu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Atherosclerosis Society 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560848/
https://www.ncbi.nlm.nih.gov/pubmed/33191364
http://dx.doi.org/10.5551/jat.58784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560848/
https://www.ncbi.nlm.nih.gov/pubmed/33191364
http://dx.doi.org/10.5551/jat.58784

Ejemplares similares